Previous Meetings

Plenary Lecture II
Venue:

Vista I+II

Neoadjuvant Therapy for Breast Cancer
Soonmyung Paik (National Surgical Adjuvant Breast and Bowel Project(NSABP) Foundation, Inc., U.S.A.)Slide View Abstract

Symposium V:

Recent Insights for Metastasis
Venue:

Vista I+II

Detection and Characterization of Circulating Tumor Cells
Simon Joosse (Univ. Medical Center Hamburg-Eppendorf, Germany)Abstract
Breast Cancer Bone Metastasis - From Molecular Insights to Novel Therapeutics
Yibin Kang (Princeton Univ., U.S.A.)Slide View Abstract
Breast Cancer and Metastasis: On the Way toward Individualized Therapy
Jean Paul Thiery (School of Medicine, National Univ. Singapore, Singapore)Abstract

Panel Session II:

Management of Local-regional Breast Cancer Recurrence: Controversial Issues
Venue:

Vista III

Surgical Issues for Management of Local-regional Breast Cancer Recurrence
Hideko Yamauchi (St. Luke's International Hospital, Japan)Abstract
Re-irradiation after Ipsilateral Breast Recurrence after BCS
Kyubo Kim (Seoul National Univ. Hospital, Korea)Slide View Abstract
Do We Need Systemic Treatment in Patients with Locoregional Recurrence?
Yee Soo Chae (Kyungpook National Univ. Hospital, Korea)Slide View Abstract

Symposium VI:

Targeting mTOR/PI3K Pathways
Venue:

Vista I+II

Oncogenic PIK3CA Mutations: Targeted Therapies and Diagnostics
Ben Ho Park (Johns Hopkins Univ., U.S.A.)Slide View Abstract
How Can We Overcome PI3K Activation? - Emerging PI3K Inhibitors
Cristian Massacesi (Novartis Pharmaceutical, France)Slide View Abstract
Targeting MTOR Pathway: Clinical Implication in Therapy
Janice Tsang (Queen Mary Hospital, The Univ. of Hong Kong, Hong Kong)Slide View Abstract

Symposium VII:

Targeting Growth Factor Pathways
Venue:

Vista III

Changing Treatment Paradigm of HER2 Positive Breast Cancer: Clinical Application of New Agents
Seock-Ah Im (Seoul National Univ. Hospital, Korea)Slide View Abstract
Brain Metastases in HER2-positive Breast Cancer Patients
Yoon Sim Yap (National Cancer Centre Singapore, Singapore)Slide View Abstract
Determinant of Resistance to Trastuzumab in Adjuvant Setting
Soonmyung Paik (National Surgical Adjuvant Breast and Bowel Project(NSABP) Foundation, Inc., U.S.A.)Slide View Abstract

Plenary Lecture III
Venue:

Vista I+II

Tailored Adjuvant Therapy Based on Genomic Assays
Hope S. Rugo (Univ. of California San Francisco Medical Center, U.S.A.)Slide View Abstract

Satellite Symposium:

The Importance of Identifying Women with Hereditary Breast and Ovarian Cancer Syndrome
Venue:

Vista III

Changing the Medical Pathway Based on BRCA Mutation Status
Peter Ang (OncoCare Cancer Centre, Singapore)Slide View
Interpreting Genetic Test Results for BRCA1 and BRCA2
Karen Copeland (Myriad Genetics GmbH, Switzerland)

Free Paper Session III:

Treatment
Venue:

Vista I+II

NO FURTHER AXILLARY DISSECTION IN SENTINEL LYMPH NODE-NEGATIVE BREAST CANCER AFTER NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH INITIAL CYTOLOGICALLY-PROVEN AXILLARY NODE METASTASIS
Min Kuk Kim (Samsung Medical Center, Korea)Abstract
ROLE OF AXILLARY CLEARANCE WITH TUMOR POSITIVE SENTINEL NODE IN MASTECTOMY GROUP: IS THE RESULTS OF ACOSOG Z0011 TRIAL ADAPTABLE TO MASTECTOMY PATIENT?
Ji Young You (National Cancer Center, Korea)Abstract
REAL-TIME 3D VIRTUAL NAVIGATION - IT AND BREAST SURGERY -
Masato Suzuki (Teikyo Univ. Chiba Medical Center, Japan)Abstract
NEOADJUVANT CHEMOTHERAPY IN YOUNG AGE BREAST CANCER: SURVIVAL BENEFIT OVER ADJUVANT CHEMOTHERAPY IN CLINICALLY T2 NODE POSITIVE PATIENTS
Min Kyoon Kim (Seoul National Univ. Hospital, Korea)Abstract
BREAST CANCER 2013: TIME TO ACKNOWLEDGE MEDICAL THERAPY FIRST
Maria Antonia Coccia-Portugal (Eastleigh Breast Care Centre, South Africa)Abstract
EARLY FAILURE OF LOCALLY ADVANCED BREAST CANCERS TO NEOADJUVANT CHEMOTHERAPY: IDENTIFYING THE PATIENTS WHO DO NOT HAVE BENEFIT FROM NEOADJUVANT CHEMOTHERAPY
Moon Ki Choi (Samsung Medical Center, Korea)Abstract
CAN POST OPERATIVE RADIOTHERAPY ADVERSELY AFFECT FLAP BASED IMMEDIATE SKIN SPARING MASTECTOMIES AND RECONSTRUCTIONS?
Eric Drabble (Derriford Hospital, United Kingdom)Abstract
A SINGLE-INSTITUTION COMPARISON BETWEEN APBI (ACCELERATED PARTIAL BREAST IRRADIATION) USING MULTICATHETER BRACHYTHERAPY AND WBI (WHOLE BREAST RADIATION) IN BREAST CANCER WITH "CAUTIONARY" OR "UNSUITABLE" BY ASTRO GUIDELINE
Kazuhiko Sato (Tokyo-West Tokushukai Hospital, Japan)Abstract
ONCOLPASTIC BREAST-CONSERVING SURGERY WITH INTERCOSTAL ARTERY PERFORATOR FLAP
Jeong Woo Lee (Kyungpook National Univ., Korea)Abstract

Free Paper Session IV:

Oncology Nursing / Quality of Life
Venue:

MGB I

THE EFFECTS OF BREAST HEALTH EDUCATION PROGRAM BASED ON SELF-EFFICACY THEORY AND PERSONAL NARRATIVE ON SELF-EFFICACY, KNOWLEDGE, AND RESILIENCE IN WOMEN WITH BREAST CANCER
Young Mi Ryu (Seoul National Univ., Korea)Abstract
QUALITATIVE ANALYSIS OF WOMEN'S KNOWLEDGE, ATTITUDES AND EXPERIENCES REGARDING URINARY SYMPTOMS ASSOCIATED WITH AROMATASE INHIBITORS FOR EARLY STAGE BREAST CANCER
Mariana De Souza E Sousa (Univ. of New South Wales, Australia)Abstract
FACTORS INFLUENCING QUALITY OF LIFE IN BREAST CANCER PATIENTS WITH HORMONE THERAPY
Eunkyung Hwang (Seoul National Univ. Hospital, Korea)Abstract
FEAR OF RECURRENCE AFTER BREAST CANCER TREATMENT
Soo Jung Park (Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan Univ., Korea)Abstract
ASSOCIATED FACTORS WITH CHANGES IN COGNITIVE FUNCTION IN BREAST CANCER PATIENTS RECEIVED CHEMOTHERAPY (BASED ON THE CONCEPTUAL MODEL OF CHEMOTHERAPY-RELATED CHANGES IN COGNITIVE FUNCTION)
Kayoung Shin (College of Nursing, Yonsei Univ., Korea)Abstract
DEVELOPMENT AND VALIDATION OF CHEMOTHERAPY-INDUCED ALOPECIA DISTRESS SCALE (CADS) FOR BREAST CANCER PATIENTS
Eun-Kyung Choi (Samsung Medical Center, Korea)Abstract
EXPERIENCE OF IRANIAN MEN IN LIVING WITH A SPOUSE WITH BREAST CANCER?
Fariba Taleghani (Isfahan Univ. of Medical Sciences, Iran)Abstract
A VALIDATION STUDY OF CANCER STIGMA SCALE FOR KOREAN PATIENTS (CSS-K)
Hyang Sook So (College of Nursing, Chonnam National Univ., Korea)Abstract

Free Paper Session V:

Prognosis and Response Prediction
Venue:

MGB II

PROGNOSTIC RELEVANCE OF BIOLOGICAL SUBTYPE OVERRIDING TNM STAGING IN BREAST CANCER: DISCORDANCE BETWEEN STAGE AND BIOLOGY
Hyun Ae Jung (Sungkyunkwan Univ., Samsung Medical Center, Korea)Abstract
THE CLINICAL IMPACT OF 21-GENE RECURRENCE SCORE ON TREATMENT DECISION FOR PATIENTS WITH HORMONE RECEPTOR - POSITIVE EARLY BREAST CANCER IN KOREA
Moo Hyun Lee (National Cancer Center, Korea)Abstract
IDENTIFICATION OF THE PATIENTS WITH A POOR PROGNOSIS AMONG ESTROGEN RECEPTOR - POSITIVE BREAST CANCER WITH THE INTERMEDIATE ONCOTYPE DX RECURRENCE SCORE
Sung Gwe Ahn (Gangnam Severance Hospital, Korea)Abstract
STANDARDIZATION OF KI67 ASSESSMENT FOR EFFICIENT USE OF THE ONCOTYPE DX ASSAY IN BREAST CANCER PATIENTS
Yoshio Mizuno (Tokyo-West Tokushukai Hospital, Japan)Abstract
CLINICAL USEFULNESS OF AUTOMATED ASSESSMENT OF KI-67 PROLIFERATIVE ACTIVITY USING A PUBLIC DOMAIN IMAGE ANALYSIS SOFTWARE, IMMUNORATIO
Min-Kyung Yeo (The Catholic Univ. of Korea, Seoul St. Mary's Hospital, Korea)Abstract
A ROLE OF BREAST DENSITY AS A PROGNOSTIC FACTOR FOR LATE DISTANT METASTASIS IN PREMENOPAUSAL, HORMONE RESPONSIVE/HER2 NEGATIVE BREAST CANCER PATIENTS AFTER COMPLETION OF 5 YEARS OF ADJUVANT THERAPY
Guiyun Sohn (ASAN Medical Center, Korea)Abstract
IMPACT OF INITIAL SURGICAL TREATMENT DELAY ON SURVIVAL ACCORDING TO HORMONE RESPONSIVENESS IN BREAST CANCER
Tae-Kyung Yoo (College of Medicine, Seoul National Univ., Korea)Abstract
MALIGNANT PHYLLODES TUMOR OF THE BREAST: CLINICAL OUTCOMES OF PATIENTS TREATED WITH SURGERY AND RADIOTHERAPY
Jihye Cha (Wonju College of Medicine, Yonsei Univ., Korea)Abstract

Education Session II:

Cancer Genomics II
Venue:

Vista III

TCGA, the Big Data for Breast Cancer – Introduction and Method for Data Mining
Ju Han Kim (Seoul National Univ. College of Medicine, Korea)Slide View Abstract
Genomic Approaches to Overcome Limitation in Tissue Access and Tumor Heterogeneity
Woong-Yang Park (Samsung Medical Center, Korea)Slide View Abstract
Clinical Trials Based on Genomics Data Mining
Iain Tan Bee Huat (National Cancer Centre, Singapore)Abstract

Insight GBCC II:

Asian Hereditary Breast Cancer
Venue:

Vista I+II

Where Are We in Asia, Two Decades after the Discovery of BRCA1 and BRCA2
Sung-Won Kim (Seoul National Univ. Bundang Hospital, Korea)Slide View Abstract
Systemic Review of BRCA Mutation and Variants of Unknown Significance in Asia
Ava Kwong (Queen Mary Hospital, Hong Kong)Abstract
Risk Assessment and Modifiers of the Risks of Breast Cancer and BRCA Mutation in Asia
Sue K. Park (Seoul National Univ. College of Medicine, Korea)Slide View Abstract
Status of Genetic Counseling and Genetic Testing in Asian Countries
Philip Iau (National Univ. Hospital, Singapore)Slide View Abstract
Early Diagnosis and Risk Reduction Strategy in BRCA Carriers
Seigo Nakamura (Showa Univ., Japan)Slide View Abstract
Outcomes for Asian BRCA Carriers
Rajiv Sarin (Tata Memorial Hospital, India)Slide View Abstract
Beyond BRCA Mutation in Hereditary Breast Cancer
Soo-Hwang Teo (Cancer Reaserch Initiatives Foundation, Malaysia)Abstract

Panel Session III:

Overcoming Challenges in Neoadjuvant Treatment
Venue:

Vista III

Upfront Surgery vs. Surgery after Neoadjuvant Chemotherapy
Eun Sook Lee (National Cancer Center, Korea)Abstract
Oncology Issue: Are We Ready to Use Different Strategy according to Intrinsic Subtypes?
Yeon Hee Park (Samsung Medical Center, Korea)Slide View Abstract
Surgical Issue: Can SLN Biopsy Guide Extent of LN Dissection after Neoadjuvant Treatment?
Joon Jeong (Gangnam Severance Hospital, Yonsei Univ., Korea)Slide View Abstract

KEEP ME UPDATED

Sign up for GBCC Newsletter

Global Breast Cancer Conference Secretariat